ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
about
Type III protein secretion systems in bacterial pathogens of animals and plantsPhages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversionExploitation of eukaryotic subcellular targeting mechanisms by bacterial effectorsUse of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesisTLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxinsAn indirect enzyme-linked immunosorbent assay for rapid and quantitative assessment of Type III virulence phenotypes of Pseudomonas aeruginosa isolates.Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a reviewCandida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine BiosynthesisIntoxication of host cells by the T3SS phospholipase ExoU: PI(4,5)P2-associated, cytoskeletal collapse and late phase membrane blebbingStructural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosaStructural evidence suggests that antiactivator ExsD from Pseudomonas aeruginosa is a DNA binding proteinVipD of Legionella pneumophila Targets Activated Rab5 and Rab22 to Interfere with Endosomal Trafficking in MacrophagesPseudomonas aeruginosa Type III Secretory Toxin ExoU and Its Predicted HomologsStructure-function aspects of PstS in multi-drug-resistant Pseudomonas aeruginosaType III secretion system expression in oxygen-limited Pseudomonas aeruginosa cultures is stimulated by isocitrate lyase activityPsrA is a positive transcriptional regulator of the type III secretion system in Pseudomonas aeruginosaThe galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung.Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion systemAn adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumoniaIdentification of a chitin-binding protein secreted by Pseudomonas aeruginosaExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa.Regulatory role of PopN and its interacting partners in type III secretion of Pseudomonas aeruginosaThe Pseudomonas aeruginosa periplasmic protease CtpA can affect systems that impact its ability to mount both acute and chronic infectionsLung infections associated with cystic fibrosis.Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A2 (PLA2) Enzyme, ExoU.Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice.Pseudomonas aeruginosa induces membrane blebs in epithelial cells, which are utilized as a niche for intracellular replication and motilityPseudomonas aeruginosa induces localized immunosuppression during pneumoniaPseudomonas aeruginosa Type III secretion system interacts with phagocytes to modulate systemic infection of zebrafish embryosThe ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells.Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors.Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.Induction of apoptosis in macrophage cell line, J774, by the cell-free supernatant from Pseudomonas aeruginosa.Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU.Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis.Comparative genomics of the emerging human pathogen Photorhabdus asymbiotica with the insect pathogen Photorhabdus luminescensThe hemolytic and cytolytic activities of Serratia marcescens phospholipase A (PhlA) depend on lysophospholipid production by PhlA.Activation of ExoU phospholipase activity requires specific C-terminal regions.Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU
P2860
Q24548602-260C0366-EC53-4771-8FEE-44985FF94A95Q24562822-E3958C4D-A9B1-4EAF-8BBD-D93221FF2C47Q24630824-1BA2EBF6-B2A1-4B87-8E1E-5BE10840B921Q24682662-0C152CB5-A2E3-4461-9AF0-FB37C7222337Q24805246-218F8002-B040-43A9-A4CF-7FCDCC4805B4Q25256862-6607D34A-10A4-4584-ACF5-6295B3F4D302Q27013824-504F65D9-5936-4077-B46E-981C41768BCAQ27317563-461FF860-68B9-4ACF-A519-26167A70648FQ27318150-68ED2FB5-616C-4856-A6F5-5DE5A4CD4510Q27346512-05557497-6501-440A-B019-6464255E6190Q27653885-2DF4F14A-FEDB-49DC-B7C3-9120BAC9FA7EQ27675624-D325D4D8-0BE4-4A54-8C46-CA09A46E4205Q28078798-661B9C93-F074-49EF-BA2F-71740B736807Q28472208-F3EDEDA0-70DB-4A70-BF58-F5F829077618Q28492462-24112688-1B4D-4FA3-9701-BCBFB0C1D4C8Q28492519-C4147E58-174F-4229-BEEB-DD7AD4D0C49BQ28492530-F16026C2-74AF-4BAF-8124-8EF83051D530Q28492902-9C8C0EE4-6544-4991-8FDA-B79868551B0EQ28492911-FB69471B-F0F9-44AA-A74E-F72ABDBC4621Q28492925-A7560B09-F771-415C-A821-F83E0806A8A8Q28492983-95DDCC71-9AFE-4AB8-83C1-C7FBD7BBE0BEQ28493109-50745E62-1A43-42F0-9752-9BA8476DB22FQ28493113-182C0625-EE30-4FD4-9BC0-8C5B3DE3D5F4Q30080000-F6C73144-8BBC-4DC0-87D5-EB36CA67550EQ30397248-EEA774A4-B337-439C-A97F-C5D20BDCAB2BQ30441643-852CEE21-4B16-4F63-8E5D-A5956C925CE9Q30481792-56090B6C-A724-46C3-ADE5-76E8E6E16075Q30483670-66AFD879-ABE0-4FD8-9656-72725112601DQ30496444-4E0ABA98-732D-4CC9-BE7F-9C730802385FQ30497320-796E9ECD-FE17-4531-B934-7F14E1EAD6C7Q31082475-C36FB134-F1B8-4835-A548-3B9B3C92B44FQ33178932-77AF1AD6-D926-4752-A37C-0778E8A7C0A1Q33180176-B8261441-48D9-4F45-BE0D-EDA2C59D5AC9Q33186884-2683580F-2944-4813-B1C9-7ED84F5EA6DDQ33267063-91DD5B02-B728-4941-AA81-1D060E23C138Q33474273-B6AB88F0-8253-4C91-8D26-DA7DD38A6679Q33479324-8014124B-B6D0-4008-92EE-D096427D486FQ33518058-07C3D667-0A9F-4EC5-B51A-9A866E51CEC8Q33526200-0D19C05A-78C2-4A17-9BE4-5C3C8CF27CE0Q33558698-CFE11C1D-9A82-4A82-AFDF-2E4817301036
P2860
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
ExoU expression by Pseudomonas ...... oxicity and epithelial injury.
@en
type
label
ExoU expression by Pseudomonas ...... oxicity and epithelial injury.
@en
prefLabel
ExoU expression by Pseudomonas ...... oxicity and epithelial injury.
@en
P2093
P1476
ExoU expression by Pseudomonas ...... oxicity and epithelial injury.
@en
P2093
Finck-Barbançon V
Fleiszig SM
Goranson J
Mende-Mueller L
Wiener-Kronish JP
P304
P356
10.1046/J.1365-2958.1997.4891851.X
P407
P577
1997-08-01T00:00:00Z